NCT05510869

Brief Summary

The aim of the study is to compare functional results and complications of 3 methods of cataract phacoemulsification: bimanual 1.4 mm cataract surgery (B-MICS), coaxial 1.8 mm cataract surgery (C-MICS) and coaxial 2.4 mm small incision cataract surgery.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

August 18, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 22, 2022

Completed
Last Updated

August 22, 2022

Status Verified

August 1, 2022

Enrollment Period

3 years

First QC Date

August 18, 2022

Last Update Submit

August 19, 2022

Conditions

Keywords

surgically induced astigmatismphacoemulsificationbimanual microincision cataract surgerycoaxial microincision cataract surgerysmall incision cataract surgeryclear corneal incision

Outcome Measures

Primary Outcomes (15)

  • the best corrected visual acuity

    examined with digital Snellen chart, measured in decimal scale

    36 months

  • the best uncorrected visual acuity

    examined with digital Snellen chart, measured in decimal scale

    36 months

  • autorefractometry

    measured in diopters (D)

    36 months

  • keratometry

    measured in diopters (D)

    36 months

  • intraocular pressure (IOP)

    measured in millimeters of mercury (mmHg)

    36 months

  • endothelial cell density (ECD)

    measured in endothelial cells/mm2

    36 months

  • central corneal thickness (CCT)

    measured with Anterior Segment Optical Coherence Tomography (AS-OCT), unit of measure: µm (micrometers).

    36 months

  • peripheral temporal corneal thickness

    measured at the main incision site with Anterior Segment Optical Coherence Tomography (AS-OCT), unit of measure: µm (micrometers)

    36 months

  • peripheral nasal corneal thickness

    measured with Anterior Segment Optical Coherence Tomography (AS-OCT), unit of measure: µm (micrometers)

    36 months

  • anterior chamber depth (ACD)

    measured with Anterior Segment Optical Coherence Tomography (AS-OCT) in mm (milimeters).

    36 months

  • the white-to-white (WTW) distance - the horizontal corneal diameter

    measured with Anterior Segment Optical Coherence Tomography (AS-OCT, unit of measure: mm (milimeters).

    36 months

  • length of the clear corneal incision

    the chord length measured with Anterior Segment Optical Coherence Tomography (AS-OCT), unit of measure: µm (micrometers)

    36 months

  • anterior chamber angle

    measured with Anterior Segment Optical Coherence Tomography (AS-OCT) in horizontal scan, unit of measure: degrees

    36 months

  • central foveal thickness (CFT)

    measured with Optical Coherence Tomography (OCT), unit of measure: µm (micrometers)

    36 months

  • parafoveal retinal thickness

    measured with Optical Coherence Tomography (OCT), unit of measure: µm (micrometers)

    36 months

Secondary Outcomes (1)

  • surgically induced astigmatism SIA

    36 months

Study Arms (3)

B-MICS 1.4 mm

EXPERIMENTAL

bimanual 1.4 mm cataract surgery (B-MICS)

Procedure: Bimanual 1.4 mm microincision cataract surgery (B-MICS) with IOL implantation in a "wound-assisted" technique. In bimanual MICS group a self-sealing 1.4 mm wide incision was created supratemporally

C-MICS 1.8 mm

ACTIVE COMPARATOR

coaxial 1.8 mm cataract surgery (C-MICS)

Procedure: Coaxial 1.8 mm microincision cataract surgery (C-MICS) with IOL implantation with an injector through the 1.8 mm wide incision created temporally.

C-SICS 2.4 mm

ACTIVE COMPARATOR

coaxial 2.4 mm small incision cataract surgery (C-SICS)

Procedure: Coaxial 2.4 mm small incision cataract surgery (C-SICS) with IOL implantation with an injector through the 2.4 mm wide incision located temporally.

Interventions

microincision cataract surgery (phacoemulsification) with implantation of a foldable, acrylic, hydrophilic IOL Incise® MJ14, Bausch \& Lomb

B-MICS 1.4 mm

microincision cataract surgery (phacoemulsification) with implantation of a foldable, acrylic, hydrophilic IOL Incise® MJ14, Bausch \& Lomb

C-MICS 1.8 mm

small incision cataract surgery (phacoemulsification) with implantation of a foldable, acrylic, hydrophilic IOL Incise® MJ14, Bausch \& Lomb

C-SICS 2.4 mm

Eligibility Criteria

Age35 Years - 87 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • cataract sclerosis grade from II to IV in Lens Opacities Classification System LOCS III scale (The Lens Opacities Classification System III).
  • history of ocular surgery, ocular trauma,
  • congenital ocular malformations, amblyopia,
  • corneal disorders (including corneal opacities and scars),
  • best corrected visual acuity (BCVA) ≥ 0.9,
  • preoperative endothelial cell density \<1500 cells/mm2,
  • history of uveitis, diabetic retinopathy,
  • retinal and macular disorders,
  • eventful phacoemulsification
  • presence of other diseases that could affect the postoperative visual outcomes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

CataractAstigmatism

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesRefractive Errors

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 18, 2022

First Posted

August 22, 2022

Study Start

January 1, 2016

Primary Completion

January 1, 2019

Study Completion

May 1, 2019

Last Updated

August 22, 2022

Record last verified: 2022-08